Amel Elshaier
Family · Crivitz, WINPI 1780166819
Payments from drug & device makers
Across 121 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$585
- Johnson & Johnson$480
- Amgen$239
- Merck$176
- Boehringer Ingelheim$123
- AstraZeneca$102
- plus $448 from 9 others
What the payments were for
- Food & beverage$2,13999%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 33 | $585 |
| Johnson & Johnson | 26 | $480 |
| Amgen | 13 | $239 |
| Merck | 12 | $176 |
| Boehringer Ingelheim | 7 | $123 |
| AstraZeneca | 6 | $102 |
| Lilly USA, LLC | 6 | $92 |
| Bayer | 4 | $87 |
| Lexicon Pharmaceuticals, Inc. | 3 | $66 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $59 |
| Novo Nordisk | 2 | $43 |
| Dexcom, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $17 |
| Pfizer | 1 | $15 |
How this compares
$2,153 in reported general payments places this provider in the 90th percentile of 1,273 family providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 100 | $98,362 |
| JardianceEmpagliflozin | 71 | $89,743 |
| FarxigaDapagliflozin Propanediol | 42 | $52,518 |
| EntrestoSacubitril/Valsartan | 61 | $41,809 |
| OzempicSemaglutide | 36 | $39,466 |
| XareltoRivaroxaban | 24 | $28,732 |
| MyrbetriqMirabegron | 31 | $23,246 |
| JanuviaSitagliptin Phosphate | 30 | $22,324 |
| TrulicityDulaglutide | 22 | $21,977 |
| Repatha SureclickEvolocumab | 30 | $20,823 |
| BrilintaTicagrelor | 14 | $14,510 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $8,056 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 31 | $8,007 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $6,874 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $6,740 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $98,362100 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $123 | $96,61783 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $102 | $73,71777 claims |
| NovartisEntresto | $585 | $41,80961 claims |
| Novo NordiskOzempic | $43 | $39,46636 claims |
| Johnson & JohnsonXarelto | $480 | $28,73224 claims |
| Astellas Pharma US IncMyrbetriq | $17 | $23,24631 claims |
| MerckJanuvia | $176 | $22,32430 claims |
| Lilly USA, LLCTrulicity | $92 | $21,97722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,273 family providers in Wisconsin.
Other family in Crivitz
- Stephanie OffordMilwaukee$763K
- Laura SwobodaMenomonee Falls$111K
- Melissa BellePrentice$62K
- Lonniel BainMadison$54K
- Linda WespGlendale$44K
- Andrea BuxtonGreen Bay$36K
- Jani CookGreen Bay$31K
- Tiffany HolleySheboygan$26K
- Kathryn SweetmanMenomonee Falls$26K
- Tracy NelsonMilwaukee$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.